Intracranial hemorrhage due to vitamin K deficiency in infants: a clinical study

C Yilmaz1, S A Yuca, N Yilmaz

  • 1Department of Pediatric Neurology, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey. drcahideyilmaz@hotmail.com

Insights

Late-onset vitamin K deficiency causes intracranial hemorrhage (ICH) in infants, leading to significant mortality. Prompt vitamin K administration can correct clotting abnormalities and prevent severe outcomes.

Area of Science:

  • Pediatrics
  • Neurology
  • Hematology

Background:

  • Late-onset vitamin K deficiency is a preventable cause of intracranial hemorrhage (ICH) in infants.
  • ICH in infants presents with diverse neurological and physical signs, including convulsions and fontanel changes.

Purpose of the Study:

  • To evaluate the clinical characteristics, management, and outcomes of infants diagnosed with intracranial hemorrhage due to vitamin K deficiency.
  • To highlight the persistent public health challenge posed by vitamin K deficiency-related ICH in Turkey.

Main Methods:

  • Retrospective evaluation of hospital records for 30 infants diagnosed with ICH from vitamin K deficiency between 2001 and 2005.
  • Analysis of clinical signs, physical examination findings, laboratory results (prothrombin time, activated partial thromboplastin time), and treatment interventions.

Main Results:

  • Common symptoms included convulsions (80%), poor sucking (50%), and irritability (40%).
  • Physical findings revealed bulging fontanel (63%) and diminished neonatal reflexes (37%).
  • All infants had prolonged PT, corrected by vitamin K; intraparenchymal hemorrhage was the most common ICH type (33% mortality).

Conclusions:

  • Intracranial hemorrhage due to vitamin K deficiency remains a significant health issue in infants.
  • High mortality rates underscore the importance of vitamin K prophylaxis and timely diagnosis.

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...